- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2020-005048-46.
Displaying page 1 of 1.
EudraCT Number: 2020-005048-46 | Sponsor Protocol Number: D9673C00007 | Start Date*: 2021-06-02 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: An Open-Label, Multinational, Multicenter, Phase 3b/4 Study of Trastuzumab Deruxtecan in Patients With or Without Baseline Brain Metastasis With Previously-Treated Advanced/Metastatic HER2-Positive... | |||||||||||||
Medical condition: Treatment of patients with HER2-positive breast cancer with or without brain metastasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) IE (Ongoing) SE (Ongoing) NO (Ongoing) BE (Ongoing) DK (Ongoing) IT (Ongoing) PT (Ongoing) PL (Ongoing) FI (Ongoing) NL (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
